ALIGN TECHNOLOGY, INC. Payments to Acquire Debt Securities, Available-for-sale
ALIGN TECHNOLOGY, INC. (ALGN) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-02-27
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-09-30 was $0.00.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $0.00.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $2.91M, a 89.61% decline from fiscal 2022.
- ALIGN TECHNOLOGY, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $28.00M, a 86.06% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | $537.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $0.00 10-Q · filed 2024-08-02 | $537.00K derived: sum of 3 quarters · filed 2026-02-27 | $537.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-03 | $537.00K derived: sum of 2 quarters · filed 2026-02-27 | $537.00K derived: sum of 3 quarters · filed 2026-02-27 | $539.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $537.00K derived: sum of 2 quarters · filed 2026-02-27 | $539.00K derived: sum of 3 quarters · filed 2026-02-27 | $2.91M 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.00K derived: sum of 2 quarters · filed 2024-11-05 | $2.37M 10-Q · filed 2024-11-05 | $9.91M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.37M 10-Q · filed 2024-08-02 | $9.91M derived: sum of 3 quarters · filed 2025-02-28 | $9.91M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.37M 10-Q · filed 2024-05-03 | $9.91M derived: sum of 2 quarters · filed 2025-02-28 | $9.91M derived: sum of 3 quarters · filed 2025-02-28 | $15.33M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $7.54M derived: sum of 2 quarters · filed 2025-02-28 | $12.96M derived: sum of 3 quarters · filed 2025-02-28 | $28.00M 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $5.42M derived: sum of 2 quarters · filed 2023-11-03 | $20.47M 10-Q · filed 2023-11-03 | $221.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $20.47M 10-Q · filed 2023-08-04 | $221.39M derived: sum of 3 quarters · filed 2024-02-28 | $221.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $15.04M 10-Q · filed 2023-05-05 | $215.97M derived: sum of 2 quarters · filed 2024-02-28 | $215.97M derived: sum of 3 quarters · filed 2024-02-28 | $215.97M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $200.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $200.93M derived: sum of 2 quarters · filed 2024-02-28 | $200.93M derived: sum of 3 quarters · filed 2024-02-28 | $200.93M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $5.34M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $5.34M 10-Q · filed 2021-11-02 | $109.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $5.34M 10-Q · filed 2021-08-04 | $109.82M derived: sum of 3 quarters · filed 2022-02-25 | |
| 2020-03-31 | $5.34M 10-Q · filed 2021-05-05 | $109.82M derived: sum of 2 quarters · filed 2022-02-25 | ||
| 2019-12-31 | $104.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $693.28M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $588.80M 10-Q · filed 2020-10-30 | |||
| 2018-12-31 | $180.19M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |